Point prevalence study of antimicrobial use among hospitals across Botswana; findings and implications

References

• Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014;5(6):229–241.
   PubMedGoogle Scholar
• Bebell LM, Muiru AN. Antibiotic use and emerging resistance: how can resource-limited countries turn the tide? Glob Heart. 2014;9(3):347–358.
   PubMedGoogle Scholar
• Founou RC, Founou LL, Essack SY. Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis. PloS One. 2017;12(12):e0189621.
   PubMed Web of Science ®Google Scholar
• Gandra S, Barter DM, Laxminarayan R. Economic burden of antibiotic resistance: how much do we really know? Clin Microbiol Infect. 2014;20(10):973–980.
   PubMed Web of Science ®Google Scholar
• O’Neill J Securing new drugs for future generations: the pipeline of antibiotics. The review of antimicrobial resistance. [cited 2019 Mar 10]. Available at URL: https://amr-review.org/sites/default/files/SECURING%20NEW%20DRUGS%20FOR%20FUTURE%20GENERATIONS%20FINAL%20WEB_0.pdf.
   Google Scholar
• Md Rezal RS, Hassali MA, Alrasheedy AA, et al. Physicians’ knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature. Expert Rev Anti Infect Ther. 2015;13(5):665–680.
   PubMed Web of Science ®Google Scholar
• Seale AC, Gordon NC, Islam J, et al. AMR Surveillance in low and middle-income settings - A roadmap for participation in the Global Antimicrobial Surveillance System (GLASS). Wellcome Open Res. 2017;2:92.
   PubMedGoogle Scholar
• WHO. 2018. Antimicrobial resistance. Fact Sheet. [cited 2019 Mar 11]. Available at URL: http://www.who.int/mediacentre/factsheets/fs194/en/.
   Google Scholar
• Abdula N, Macharia J, Motsoaledi A, et al. National action for global gains in antimicrobial resistance. Lancet. 2016;387(10014):e3–5.
   PubMed Web of Science ®Google Scholar
• Ashiru-Oredope D, Hopkins S. Antimicrobial resistance: moving from professional engagement to public action. J Antimicrob Chemother. 2015;70(11):2927–2930.
   PubMed Web of Science ®Google Scholar
• Cox JA, Vlieghe E, Mendelson M, et al. Antibiotic stewardship in low-and middle-income countries: ‘same, but different’? Clin Microbiol Infect. 2017;23(11):812–818.
   PubMed Web of Science ®Google Scholar
• Jinks T, Lee N, Sharland M, et al. A time for action: antimicrobial resistance needs global response. Bull World Health Organ. 2016;94(8):558–a.
   PubMed Web of Science ®Google Scholar
• WHO. Global action plan on antimicrobial resistance. [cited 2019 Mar 10]. Available at URL: http://www.who.int/antimicrobial-resistance/publications/global-action-plan/en/[
   Google Scholar
• Mendelson M, Matsoso MP. The world health organization global action plan for antimicrobial resistance. South Afr Med J. 2015;105(5):325.
   PubMed Web of Science ®Google Scholar
• Dar OA, Hasan R, Schlundt J, et al. Exploring the evidence base for national and regional policy interventions to combat resistance. Lancet. 2016;387(10015):285–295.
   PubMed Web of Science ®Google Scholar
• Van Dijck C, Vlieghe E, Cox JA. Antibiotic stewardship interventions in hospitals in low-and middle-income countries: a systematic review. Bull World Health Organ. 2018;96(4):266–280.
   PubMed Web of Science ®Google Scholar
• Wesangula E, Guantai A. Oluka M. KENYAN NATIONAL ACTION PLAN ON ANTIMICROBIALS. 3rd MURIA Training Workshops and Symposium. Available at URL: file:///C:/Users/mail/Downloads/Kenyan-NAP-Antimicrobials-EWesangula%252c-AGuantai%252c-MOluka.pdf.
   Google Scholar
• Mendelson M, Brink A, Gouws J, et al. The One Health stewardship of colistin as an antibiotic of last resort for human health in South Africa. Lancet Infect Dis. 2018;18(9):e288–e94.
   PubMed Web of Science ®Google Scholar
• Falagas ME, Rafailidis PI. Re-emergence of colistin in today’s world of multidrug-resistant organisms: personal perspectives. Expert Opin Investig Drugs. 2008;17(7):973–981.
   PubMed Web of Science ®Google Scholar
• Massele A, Tiroyakgosi C, Matome M, et al. Research activities to improve the utilization of antibiotics in Africa. Expert Rev Pharmacoecon Outcomes Res. 2017;17(1):1–4.
   PubMed Web of Science ®Google Scholar
• Dyar OJ, Beovic B, Vlahovic-Palcevski V, et al. How can we improve antibiotic prescribing in primary care? Expert Rev Anti Infect Ther. 2016;14(4):403–413.
   PubMed Web of Science ®Google Scholar
• Kalungia AC, Burger J, Godman B, et al. Non-prescription sale and dispensing of antibiotics in community pharmacies in Zambia. Expert Rev Anti Infect Ther. 2016;14(12):1215–1223.
   PubMed Web of Science ®Google Scholar
• Alhomoud F, Aljamea Z, Almahasnah R, et al. Self-medication and self-prescription with antibiotics in the Middle East-do they really happen? A systematic review of the prevalence, possible reasons, and outcomes. Inter J Infect Dis. 2017;57:3–12.
   PubMed Web of Science ®Google Scholar
• Nepal G, Bhatta S. Self-medication with antibiotics in WHO Southeast Asian Region: a systematic review. Cureus. 2018;10(4):e2428.
   PubMed Web of Science ®Google Scholar
• Köchling A, Löffler C, Reinsch S, et al. Reduction of antibiotic prescriptions for acute respiratory tract infections in primary care: a systematic review. Implement Sci. 2018;13(1):47.
   PubMed Web of Science ®Google Scholar
• Fridkin S, Baggs J, Fagan R, et al. Vital signs: improving antibiotic use among hospitalized patients. Morbidity Mortality Weekly Rep. 2014;63(9):194–200.
   PubMed Web of Science ®Google Scholar
• Akhloufi H, Streefkerk RH, Melles DC, et al. Point prevalence of appropriate antimicrobial therapy in a Dutch university hospital. Eur J Clin Microbiol Infect Dis. 2015;34(8):1631–1637.
   PubMed Web of Science ®Google Scholar
• Dumartin C, L’Heriteau F, Pefau M, et al. Antibiotic use in 530 French hospitals: results from a surveillance network at hospital and ward levels in 2007. J Antimicrob Chemother. 2010;65(9):2028–2036.
   PubMed Web of Science ®Google Scholar
• Hecker MT, Aron DC, Patel NP, et al. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Internal Med. 2003;163(8):972–978.
   PubMedGoogle Scholar
• Pollmann AS, Bailey BJG, Davis PJ, et al. Antibiotic use among older adults on an acute care general surgery service. Can J Surg. 2017;60(6):388-393.
   Web of Science ®Google Scholar
• Baig MT, Sial AA, Huma A, et al. Irrational antibiotic prescribing practice among children in critical care of tertiary hospitals. Pak J Pharm Sci. 2017;30(4(Suppl.)):1483–1489.
   PubMed Web of Science ®Google Scholar
• Atif M, Azeem M, Saqib A, et al. Investigation of antimicrobial use at a tertiary care hospital in Southern Punjab, Pakistan using WHO methodology. Antimicrob Resist Infect Control. 2017;6:41.
   PubMed Web of Science ®Google Scholar
• Flanders SA, Saint S. Why does antimicrobial overuse in hospitalized patients persist? JAMA Intern Med. 2014;174(5):661–662.
   PubMed Web of Science ®Google Scholar
• Bizo PT, Dumitras D, Popa A. Evaluation of restricted antibiotic use in a hospital in Romania. Int J Clin Pharm. 2015;37(3):452–456.
   PubMed Web of Science ®Google Scholar
• Okoth C, Opanga S, Okalebo F, et al. Point prevalence survey of antibiotic use and resistance at a referral hospital in Kenya: findings and implications. Hosp Pract. 2018;46(3):128–136.
   PubMedGoogle Scholar
• Gandra S, Singh SK, Jinka DR, et al. Point prevalence surveys of antimicrobial use among hospitalized children in six hospitals in India in 2016. Antibiotics. 2017;6(3):19.
   Google Scholar
• Talaat M, Saied T, Kandeel A, et al. a point prevalence survey of antibiotic use in 18 hospitals in Egypt. Antibiotics. 2014;3(3):450–460.
   Google Scholar
• Tiroyakgosi C, Matome M, Summers E, et al. Ongoing initiatives to improve the use of antibiotics in Botswana: university of Botswana symposium meeting report. Expert Rev Anti Infect Ther. 2018;16(5):381–384.
   PubMedGoogle Scholar
• Momanyi L, Opanga S, Nyamu D, et al. Antibiotic prescribing patterns at a leading referral hospital in kenya: a point prevalence survey. Accepted Publ J Res Pharm Pract. [cited 2019 Jun 8]. Available at URL: https://strathprints.strath.ac.uk/66791/.
   Google Scholar
• Dlamini NN, Meyer JC, Kruger D, et al. Feasibility of using point prevalence surveys to assess antimicrobial utilisation in public hospitals in South Africa; a pilot study and implications. Hosp Pract. 2019;47(2):88–95.
   PubMedGoogle Scholar
• Saleem Z, Hassali MA, Versporten A, et al. A multicenter point prevalence survey of antibiotic use in Punjab, Pakistan: findings and implications. Expert Rev Anti Infect Ther. 2019; 17(4):285-293.
   Web of Science ®Google Scholar
• Lima-Dellamora Eda C, Caetano R, Gustafsson LL, et al. An analytical framework for assessing drug and therapeutics committee structure and work processes in tertiary Brazilian hospitals. Basic Clin Pharmacol Toxicol. 2014;115(3):268–276.
   PubMed Web of Science ®Google Scholar
• Matlala M, Gous AG, Godman B, et al. Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications. Expert Rev Clin Pharmacol. 2017;10(11):1273–1280.
   PubMed Web of Science ®Google Scholar
• Schellack N, Bronkhorst E, Coetzee R, et al. SASOCP position statement on the pharmacist’s role in antibiotic stewardship 2018. S Afr J Infect Dis. 2018;33(1):28–35.
   Google Scholar
• H VA F, Whitelaw A, Goossens H, et al. The global point prevalence survey of antimicrobial consumption and resistance (Global-PPS): results of antimicrobial prescribing in a South African Tertiary Hospital. 2016. Available at URL: http://www.global-pps.com/wp-content/uploads/ECCMID-2016_South-Africa.pdf
   Google Scholar
• Versporten A, Zarb P, Caniaux I, et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Health. 2018;6(6):e619–e29.
   PubMed Web of Science ®Google Scholar
• Nakwatumbah S, Kibuule D, Godman B, et al. Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia’s national referral hospital: a pilot study and the implications. Expert Rev Anti Infect Ther. 2017;15(7):713–721.
   PubMed Web of Science ®Google Scholar
• Matsitse TB, Helberg E, Meyer JC, et al. Compliance with the primary health care treatment guidelines and the essential medicines list in the management of sexually transmitted infections in correctional centres in South Africa: findings and implications. Expert Rev Anti Infect Ther. 2017;15(10):963–972.
   PubMed Web of Science ®Google Scholar
• Niaz Q, Godman B, Massele A, et al. Validity of World Health Organisation prescribing indicators in Namibia’s primary healthcare: findings and implications. Int J Qual Health Care. 2019;31(5):338–345.
   PubMed Web of Science ®Google Scholar
• Mashalla Y, Setlhare V, Massele A, et al. Assessment of prescribing practices at the primary healthcare facilities in Botswana with an emphasis on antibiotics: findings and implications. Int J Clin Pract. 2017;71:12.
   Web of Science ®Google Scholar
• Momanyi L, Oluka M, Opanga S, et al. Antibiotic prescribing patterns at a referral hospital in Kenya: A point prevalence survey. Muria 4. 2018;7. Available at URL: file:///C:/Users/mail/Downloads/Consolidated-abstract-booklet%20(4).pdf
   Google Scholar
• Labi A-K, Obeng-Nkrumah N, Nartey ET, et al. Antibiotic use in a tertiary healthcare facility in Ghana: a point prevalence survey. Antimicrob Resist Infect Control. 2018;7:15.
   PubMed Web of Science ®Google Scholar
• Labi AK, Obeng-Nkrumah N, Owusu E, et al. Multi-centre point-prevalence survey of hospital-acquired infections in Ghana. J Hosp Infect. 2019;101(1):60-68.
   Web of Science ®Google Scholar
• Ahoyo TA, Bankole HS, Adeoti FM, et al. Prevalence of nosocomial infections and anti-infective therapy in Benin: results of the first nationwide survey in 2012. Antimicrob Resist Infect Control. 2014;3:17.
   PubMed Web of Science ®Google Scholar
• Afriyie DK, Amponsah SK, Dogbey J, et al. A pilot study evaluating the prescribing of ceftriaxone in hospitals in Ghana: findings and implications. Hosp Pract (1995). 2017;45(4):143–149.
   PubMedGoogle Scholar
• van der Sandt N, Schellack N, Mabope LA, et al. Surgical antimicrobial prophylaxis among pediatric patients in South Africa comparing two healthcare settings. Pediatr Infect Dis J. 2019;38(2):122–126.
   PubMed Web of Science ®Google Scholar
• Ghosn J, Taiwo B, Seedat S, et al. HIV. Lancet. 2018;392(10148):685–697.
   PubMed Web of Science ®Google Scholar
• Wanyiri JW, Kanyi H, Maina S, et al. Infectious diarrhoea in antiretroviral therapy-naïve HIV/AIDS patients in Kenya. Trans R Soc Trop Med Hyg. 2013;107(10):631–638.
   PubMed Web of Science ®Google Scholar
• Reardon S. Antibiotic resistance sweeping developing world. Nature. 2014;509(7499):141–142.
   PubMed Web of Science ®Google Scholar
• Van Boeckel TP, Gandra S, Ashok A, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14(8):742–750.
   PubMed Web of Science ®Google Scholar
• UNDP on Botswana HIV. [cited 2019 Mar 11]. Available at URL: http://www.bw.undp.org/content/botswana/en/home/ourwork/hiv_aids/overview.html
   Google Scholar
• UNAIDS. Prevention Gap report 2016. [cited 2019 Mar 10]. Available at URL: http://www.unaids.org/sites/default/files/media_asset/2016-prevention-gap-report_en.pdf
   Google Scholar
• Massele A, Burger J, Katende-Kyenda NL, et al. Outcome of the first medicines utilization research in Africa group meeting to promote sustainable and rational medicine use in Africa. Expert Rev Pharmacoecon Outcomes Res. 2015;15(6):885–888.
   PubMed Web of Science ®Google Scholar
• Tafuma TA, Burnett RJ, Huis I, et al. National guidelines not always followed when diagnosing smear-negative pulmonary tuberculosis in patients with HIV in Botswana. PloS One. 2014;9(2):e88654.
   PubMed Web of Science ®Google Scholar
• ECDC. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. Available at URL: http://ecdc.europa.eu/en/publications/Publications/PPS-HAI-antimicrobial-use-EU-acute-care-hospitals-V5-3.pdf
   Google Scholar
• Kibuule D, Verbeeck RK, Nunurai R, et al. Predictors of tuberculosis treatment success under the DOTS program in Namibia. Expert Rev Respir Med. 2018;12(11):979–987.
   PubMed Web of Science ®Google Scholar
• Mwita SJM, Marwa K, Hamasaki K, et al. Medicines dispensers’ knowledge on the implementation of an artemisinin-based combination therapy policy for the treatment of uncomplicated malaria in Tanzania. J Pharm Health Serv Res. 2017;8:227–233.
   Google Scholar
• Paramadhas BDA, Tiroyakgosi C, Godman B. A point prevalence study on antibiotic utilization among public hospitals in Botswana. Muria 2. 2016;7. Available at URL: file:///C:/Users/mail/Downloads/Anti-infectives.pdf
   Google Scholar
• Schellack N, Dlamini N, Meyer JC, et al. Point prevalence survey of antimicrobial utilisation in an academic hospital in the Gauteng province, South Africa. Muria 3. 2017;7. Available at URL: http://muria.mandela.ac.za/muria/media/Store/documents/Abstract%20book%20-%20MURAI%203/MURIA3-AbstractBook-July-2017.pdf
   Google Scholar
• Mtapuri-Zinyowera S, Tarupiwa A, Manangazira P, et al. Investigation of foodborne pathogens and their antimicrobial resistance in humans, animals and the environment – a pilot project for Zimbabwe. Muria 4. 2018;11. Available at URL: file:///C:/Users/mail/Downloads/Consolidated-abstract-booklet%20(4).pdf
   Google Scholar
• Mpinda-Joseph P, Paramadhas BDA, Reyes G, et al. Point prevalence survey to estimate the true burden of healthcare associated infections and their risk factors in Nyangabgwe Hospital, Botswana. Muria 4. 2018;9. Available at URL: file:///C:/Users/mail/Downloads/Consolidated-abstract-booklet%20(4).pdf
   Google Scholar
• Molefhi L, Paramadhas BDA, Phiri HR, et al. Trends in utilization of parenteral antibiotics from 2014–2016 at Nyangabgwe Hospital, Botswana. Muria 4. 2018;8. Available at URL: file:///C:/Users/mail/Downloads/Consolidated-abstract-booklet%20(4).pdf
   Google Scholar
• Malone B, Phiri M, Kurusa G. Evolution of ESKAPE organism antibiotic sensitivity over time at a private hospital in Botswana. MURIA 2 Anti-Infectves. 2016;3. Available at URL: file:///C:/Users/mail/Downloads/Anti-infectives%20(1).pdf
   Google Scholar
• Mwita JC, Souda S, Magafu M, et al. Prophylactic antibiotics to prevent surgical site infections in Botswana: findings and implications. Hosp Pract. 2018;46(3):97–102.
   PubMedGoogle Scholar
• Didimalang T, Jolomba C. Antimicrobial stewardship implementation in gaborone private hospital. MURIA 2 Anti-Infectives. 2016;6. Available at URL: file:///C:/Users/mail/Downloads/Anti-infectives%20(1).pdf
   Google Scholar
• Bda P, Kgatlwane J, Tiroyakgosi C, et al. Antibiotic utilization studies using point prevalence survey in Botswana. Muria 3. 2017;8. Available at URL: http://muria.mandela.ac.za/muria/media/Store/documents/Abstract%20book%20-%20MURAI%203/MURIA3-AbstractBook-July-2017.pdf
   Google Scholar
• Motlapele D. 2017. Statistics botswana. Health statistics stats brief 2007–2015. [cited 2019 Mar 12]. Available at URL: http://www.statsbots.org.bw/sites/default/files/publications/Health%20Statistics%20Stats%20Brief%202007_2015.pdf
   Google Scholar
• WHO. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index. [cited 2019 Mar 11]. Available at URL: https://www.whocc.no/
   Google Scholar
• ECDC. 2011–2012. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. [cited 2019 Mar 12]. Available at URL: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/healthcare-associated-infections-antimicrobial-use-PPS.pdf.
   Google Scholar
• WHO. 2017. WHO collaborating centre for drug statistics methodology. Guidelines for ATC Classification and DDD Assignment. Available at URL: https://www.whocc.no/filearchive/publications/2017_guidelines_web.pdf
   Google Scholar
• Saleem Z, Hassali MA, Godman B, et al. A multicenter point prevalence survey of health care-associated infections in Pakistan: findings and implications. Am J Infect Control. 2019; 47(4):421-424.
   Google Scholar
• Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the national surgical infection prevention project. Clinl Infect Dis. 2004;38:1706-1715.
   Web of Science ®Google Scholar
• de Jonge SW, Gans SL, Atema JJ, et al. Timing of preoperative antibiotic prophylaxis in 54,552 patients and the risk of surgical site infection: A systematic review and meta-analysis. Medicine (Baltimore). 2017;96(29):e6903.
   PubMed Web of Science ®Google Scholar
• Ban KA, Minei JP, Laronga C, et al. Executive summary of the American College of Surgeons/surgical infection society surgical site infection guidelines-2016 update. Surg Infect (Larchmt). 2017;18(4):379–382.
   PubMed Web of Science ®Google Scholar
• Opanga SA, Mwang’ombe NJ, Okalebo FA, et al. Determinants of the Effectiveness of Antimicrobial Prophylaxis among Neurotrauma Patients at a Referral Hospital in Kenya: findings and Implications. Infect Dis Preve Med. 2017;5(3):1-7.
   Google Scholar